Clinical trial

Safety, Efficacy and Psychological Effects of Treating Antiretroviral…

NCT00333684 · Canadian Immunodeficiency Research Collaborative, Other · Completed

Key facts

NCT number NCT00333684
Title Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid
Official title A Prospective Study Evaluating the Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid Soft Tissue Endoprosthesis
Lead sponsor Canadian Immunodeficiency Research Collaborative, Other
Collaborators Pur Medical Corporation
Status Completed
Phase Phase 2
Study type Interventional
Conditions Human Immunodeficiency Virus, Facial Lipoatrophy
Intervention type Device
Interventions BIO-ALCAMID SOFT TISSUE ENDOPROSTHESIS
Enrollment 36
Start date Dec 1, 2004
Primary completion Nov 1, 2006
Completion May 1, 2010
First posted Jun 6, 2006
Last update posted Jun 5, 2012
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies